Matches in Wikidata for { <http://www.wikidata.org/entity/Q64188635> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q64188635 description "clinical trial" @default.
- Q64188635 description "ensayu clínicu" @default.
- Q64188635 description "klinisch onderzoek" @default.
- Q64188635 description "клінічне випробування" @default.
- Q64188635 name "Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer" @default.
- Q64188635 type Item @default.
- Q64188635 label "Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer" @default.
- Q64188635 prefLabel "Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer" @default.
- Q64188635 P1132 Q64188635-E6B63F2E-5F56-4BFD-A9A4-2BA58B0558D3 @default.
- Q64188635 P1476 Q64188635-15237B6E-3597-40C6-803D-530FA7245707 @default.
- Q64188635 P17 Q64188635-0A514CFE-D473-4A82-87D8-8507C77ADF25 @default.
- Q64188635 P17 Q64188635-25051C97-7371-4CA6-ABE2-AF7CFA8A497F @default.
- Q64188635 P17 Q64188635-275B3C08-A1F8-47EE-844A-61C08AC233D0 @default.
- Q64188635 P17 Q64188635-2E2F7C50-AFC8-474E-90CC-1983805A86D4 @default.
- Q64188635 P17 Q64188635-38E97293-56D5-4C44-8195-4148522B3016 @default.
- Q64188635 P17 Q64188635-3CFA3B7F-A76D-488E-BAA6-55758BDFE043 @default.
- Q64188635 P17 Q64188635-530B09DF-3028-461A-95CB-A2460351B170 @default.
- Q64188635 P17 Q64188635-6FEA030A-A3F2-47EF-9A5C-34104320CF90 @default.
- Q64188635 P17 Q64188635-879202CD-BEF7-4A08-971B-0EEC0539C72C @default.
- Q64188635 P17 Q64188635-A5677073-839C-41BF-8E45-83B4BCEFCEFD @default.
- Q64188635 P17 Q64188635-CA1B6261-F91B-4F11-BCE3-19EC6B440DD2 @default.
- Q64188635 P17 Q64188635-E1DB7BE8-15FA-42CF-A4C8-FBC99F04AC0C @default.
- Q64188635 P1813 Q64188635-4F78D7CD-C400-48CC-A283-58D81833A3EF @default.
- Q64188635 P2899 Q64188635-A63D9AA8-2C99-4980-A218-C0DAAF31DA3A @default.
- Q64188635 P3098 Q64188635-5DDF5400-21A6-47D3-9B3C-92E8304FFBAD @default.
- Q64188635 P31 Q64188635-102F3F91-222E-4CB3-94AE-FE60BA562CC0 @default.
- Q64188635 P4844 Q64188635-51FBC9FE-E185-4D13-ADBC-DA5EE65FCB2F @default.
- Q64188635 P4844 Q64188635-D99F3CB5-7CF8-4DEE-A1CE-7AABDE6B61C0 @default.
- Q64188635 P580 Q64188635-BD501975-C6AB-4A96-8C74-55EEDD6104E7 @default.
- Q64188635 P582 Q64188635-6704E095-9F25-4BA4-A57C-7C4810FF98FB @default.
- Q64188635 P6099 Q64188635-23C3C937-70E5-4329-B579-F2C5CC89E726 @default.
- Q64188635 P6153 Q64188635-184A6F50-C4C6-4E9C-B2B3-F0F5FAF6581C @default.
- Q64188635 P6153 Q64188635-8DD88721-D9C3-413E-80F2-0C9779473E6D @default.
- Q64188635 P8363 Q64188635-692E9F03-E3D4-4542-B8FA-745AD13454B5 @default.
- Q64188635 P859 Q64188635-1C259748-08A1-44A2-89AA-AAF15736D1B4 @default.
- Q64188635 P1132 "+202" @default.
- Q64188635 P1476 "An Open-label, Phase II, Single-arm Study of Everolimus in Combination With Letrozole in the Treatment of Postmenopausal Women With Estrogen Receptor Positive HER2 Negative Metastatic or Locally Advanced Breast Cancer" @default.
- Q64188635 P17 Q142 @default.
- Q64188635 P17 Q145 @default.
- Q64188635 P17 Q155 @default.
- Q64188635 P17 Q17 @default.
- Q64188635 P17 Q28 @default.
- Q64188635 P17 Q29 @default.
- Q64188635 P17 Q30 @default.
- Q64188635 P17 Q414 @default.
- Q64188635 P17 Q43 @default.
- Q64188635 P17 Q45 @default.
- Q64188635 P17 Q55 @default.
- Q64188635 P17 Q869 @default.
- Q64188635 P1813 "Bolero-4" @default.
- Q64188635 P2899 "+18" @default.
- Q64188635 P3098 "NCT01698918" @default.
- Q64188635 P31 Q30612 @default.
- Q64188635 P4844 Q32089 @default.
- Q64188635 P4844 Q408524 @default.
- Q64188635 P580 "2013-03-07T00:00:00Z" @default.
- Q64188635 P582 "2020-06-04T00:00:00Z" @default.
- Q64188635 P6099 Q42824440 @default.
- Q64188635 P6153 Q507154 @default.
- Q64188635 P6153 Q7896459 @default.
- Q64188635 P8363 Q78089383 @default.
- Q64188635 P859 Q507154 @default.